SUCCESSFUL USE OF THE SPERM MOTILITY ENHANCER 2-DEOXYADENOSINE IN PREVIOUSLY FAILED HUMAN INVITRO FERTILIZATION

被引:22
作者
IMOEDEMHE, DAG
SIGUE, AB
PACPACO, EA
OLAZO, AB
机构
[1] Human Reproductive Biology Unit, Soliman Fakeeh Hospital, Jeddah, 21461
关键词
ASTHENOSPERMIA; 2-DEOXYADENOSINE; MOTILITY ENHANCER;
D O I
10.1007/BF01204115
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The outcome of in vitro fertilization treatment in male-factor infertility is generally poor, due mainly to poor fertilization rate and hence fewer available embryos for replacement. This study was carried out to assess the value of asthenospermic sperm exposure to a motility enhancing agent, 2-deoxyadenosine (2-DXA), on our in vitro fertilization program in couples undergoing repeat treatment after previous failed fertilization. Following sperm wash and incubation in 2-DXA-supplemented medium, marked significant improvements were observed in the sperm motility pattern and the number of recoverable sperms as compared to control unexposed samples. There was also a significantly better fertilization rate and higher number of replaceable embryos available following sperm wash in 2-DXA as compared to those washed without it. Following embryo transfer, pregnancy rate was comparable to the generally reported pregnancy rates for routine in vitro fertilization and embryo transfer treatment. Three normal babies were born. Our results indicate that 2-DXA enhances fertilization rate in some asthenospermic patients and that it has no adverse effect on embryonic development.
引用
收藏
页码:53 / 56
页数:4
相关论文
共 13 条
  • [1] Cohen J., Edwards R., Fehilly C., Fischel S., Hewitt J., Purdy J., Roland G., Steptoe P., Webster J., In vitro fertilization treatment for male infertility, Fertil Steril, 43, pp. 422-432, (1985)
  • [2] Yovich J.L., Stanger J.D., The limitation of in vitro fertilization from males with severe oligospermia and abnormal sperm morphology, J Vitro Fert Embryo Transfer, 1, pp. 172-179, (1984)
  • [3] De Krester D.M., Yates C.A., Kovacs G.T., The use of in vitro fertilization in the management of male infertility, Clin Obstet Gynaecol, 12, pp. 767-775, (1985)
  • [4] Kruger T.F., Menkveld R., Stander F.S.H., Lombard C.J., Van der Merwe J.P., Van Zyl J.A., Smith K., Sperm morphologic features as a prognostic factor in in vitro fertilization, Fertil Steril, 46, pp. 1118-1123, (1986)
  • [5] Awadalla S.G., Friedman C.I., Schmidt G., Chin N., Kim M.H., In vitro fertilization and embryo transfer as a treatment for male factor infertility, Fertil Steril, 47, pp. 807-811, (1987)
  • [6] Jones H.W., Indications for in vitro fertilization, In Vitro Fertilization Norfolk, pp. 1-7, (1986)
  • [7] Mahadevan M.M., Trounson O.A., The influence of seminal characteristics on the success rate of human in vitro fertilization, Fertil Steril, 42, pp. 400-405, (1984)
  • [8] Bongso T.A., Ng S.C., Mok H., Lim M.N., Teo H.L., Wong P.C., Ratnam S.S., The influence of sperm motility on human in vitro fertilization, Arch Androl, 22, pp. 185-190, (1989)
  • [9] Ng S.C., Bongso T.A., Ratnam S.S., Sathananthan A.H., Chan C.L.K., Wong P.C., Hagglund L., Anandakumar C., Wong Y.C., Goh V.H.H., Pregnancy after transfer of multiple sperms under the zona, Lancet, 2, (1988)
  • [10] Malter H.E., Cohen J., Partial zona dissection of human oocyte: A nontraumatic method using micromanipulation to assist zona pellucida penetration, Fertil Steril, 51, pp. 139-148, (1989)